Childrens Cancer Therapy Development Institute
Programs
Program 1 [2018]
RESEARCHOUR CURRENT PRIMARY FOCUS ARES ARE RHABDOMYOSARCOMA, NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMES (NRSTS) INCLUDING EPITHELIOID SARCOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, PEDIATRIC HIGH GRADE GLIOMA, NF1-ASSOCIATED LOW GRADE GLIOMA, ETMR, HEPATOBLASTOMA, OSTEOSARCOMA, CLEAR CELL SARCOMA/EWING'S SARCOMA, AND MEDULLOBLASTOMA. WE ADDRESS PEDIATRIC CANCERS THAT OCCUR ACROSS ALL AGE RANGES FROM CHILDREN TO ADOLESCENTS, YOUNG ADULTS AND OLDER ADULTS.GeographiesNot indicatedDatesJul 1, 2017 – Jun 30, 2018Source990No causes providedNo populations provided–$1.5MProgram 2 [2018]
EDUCATIONWITH STRONG RESEARCH COMES EDUCATION. WE SUPPORT POSTDOCTORAL FELLOWS AND TRAVEL TO EXCHANGE DATA AND SCIENTIFIC INSIGHTS WITH COLLEAGUES ACROSS THE COUNTRY TO SHED LIGHT ON OUR EFFORTS TO MAKE CHILDHOOD CANCER UNIVERSALLY SURVIVABLE, REGARDLESS OF DIAGNOSIS. WE ALSO HAVE A COMMUNITY EDUCATION MISSION, WICH INCLUDES OUR ANNUAL PEDIATRIC CANCER NANOCOURSE.GeographiesNot indicatedDatesJul 1, 2017 – Jun 30, 2018Source990No causes providedNo populations provided–$46.8KPediatric Cancer Research
RESEARCHOUR CURRENT PRIMARY FOCUS AREAS ARE RHABDOMYOSARCOMA, NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMES (NRSTS) INCLUDING EPITHELIOID SARCOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, PEDIATRIC HIGH GRADE GLIOMA, HEPATOBLASTOMA, OSTEOSARCOMA, CLEAR CELL SARCOMA/EWING'S SARCOMA, WILMS' TUMOR, AND MEDULLOBLASTOMA. WE ADDRESS PEDIATRIC CANCERS THAT OCCUR ACROSS ALL AGE RANGES FROM CHILDREN TO ADOLESCENTS, YOUNG ADULTS AND OLDER ADULTS.GeographiesNot indicatedDatesJul 1, 2023 – Jun 30, 2024Source990No causes providedNo populations provided–$2.1M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)